Simultaneous transfer of cholesterol, triglycerides, and phospholipids to high-density lipoprotein in aging subjects with or without coronary artery disease

Carregando...
Imagem de Miniatura
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Autores
AZEVEDO, Carolina H. M.
PRETE, Ana C. Lo
Citação
CLINICS, v.66, n.9, p.1543-1548, 2011
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVE: To verify whether the capacity of high-density lipoprotein (HDL) to simultaneously receive non-esterified cholesterol, triglycerides, cholesteryl esters, and phospholipids changes with aging and the presence of coronary artery disease. DESIGN: Cross-sectional study with biochemical analyses. SUBJECTS: Eleven elderly patients with coronary artery disease (74 +/- 5 years) were compared with the following groups of non-coronary artery disease subjects (referred to as ""healthy""): 25 young (25 +/- 5 years), 25 middle-aged (42 +/- 6 years), and 25 elderly subjects (75 +/- 8 years). METHODS: Plasma samples were incubated with a nanoemulsion labeled with radioactive lipids; the transfer of the lipids from the nanoemulsion to the HDL was measured in chemically precipitated HDL. HDL size and paraoxonase-1 activity were also determined. RESULTS: The transfer of cholesteryl esters and phospholipids to high-density lipoprotein was significantly greater (p<0.001) in healthy elderly subjects than in the middle-aged and younger subjects. Non-esterified cholesterol and triglyceride transfer was not different among these three groups. The HDL size was significantly greater (p<0.001) in healthy elderly subjects than in the middle-aged and younger subjects. The paraoxonase-1 activity was similar among the groups. Compared with healthy elderly subjects, coronary artery disease elderly subjects had significantly less (p<0.05) transfer of non-esterified cholesterol, triglycerides, and cholesteryl esters to the HDL and a significantly smaller (p<0.05) HDL size. CONCLUSION: Because lipid transfer is enhanced in healthy elderly subjects but not in those with coronary artery disease, increasing lipid transfer to HDL may be a protective mechanism against the disease.
Palavras-chave
Aging, cholesteryl ester transfer protein (CETP), transfer proteins, lipoproteins, nanoparticles
Referências
  1. von Eckardstein A, 2001, ARTERIOSCL THROM VAS, V21, P13
  2. Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200
  3. Terry DF, 2007, ARCH INTERN MED, V167, P438, DOI 10.1001/archinte.167.5.438
  4. MACKNESS MI, 1991, ATHEROSCLEROSIS, V86, P193, DOI 10.1016/0021-9150(91)90215-O
  5. Chapman MJ, 2010, EUR HEART J, V31, P149, DOI 10.1093/eurheartj/ehp399
  6. Natarajan P, 2010, J AM COLL CARDIOL, V55, P1283, DOI 10.1016/j.jacc.2010.01.008
  7. Ferretti G, 2006, ATHEROSCLEROSIS, V184, P1, DOI 10.1016/j.atherosclerosis.2005.08.008
  8. Costa LG, 2005, BIOCHEM PHARMACOL, V69, P541, DOI 10.1016/j.bcp.2004.08.027
  9. Rashid S, 2003, CLIN BIOCHEM, V36, P421, DOI 10.1016/S0009-9120(03)00078-X
  10. Berrougui H, 2007, J LIPID RES, V48, P328, DOI 10.1194/jlr.M600167-JLR200
  11. Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/S0021-9150(96)90501-8
  12. MARANHAO RC, 1993, LIPIDS, V28, P691, DOI 10.1007/BF02535988
  13. Barter PJ, 2006, CURR OPIN LIPIDOL, V17, P399, DOI 10.1097/01.mol.0000236365.40969.af
  14. Cheung MC, 1999, ATHEROSCLEROSIS, V142, P201
  15. Cutri BA, 2006, CELL RES, V16, P799, DOI 10.1038/sj.cr.7310097
  16. Dantas SA, 2010, CLINICS, V65, P23, DOI 10.1590/S1807-59322010000100005
  17. Falk E, 2006, J AM COLL CARDIOL, V47, pC7, DOI 10.1016/j.jacc.2005.09.068
  18. FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499
  19. Heijmans BT, 2006, PLOS MED, V3, P2317, DOI 10.1371/journal.pmed.0030495
  20. Lewis GF, 2006, CIRC RES, V96, P122
  21. Lima ES, 2004, CLIN CHEM, V50, P1086, DOI 10.1373/clinchem.2004.032383
  22. Lo Prete AC, 2009, LIPIDS, V44, P917, DOI 10.1007/s11745-009-3342-2
  23. Norata GD, 2006, NUTR METAB CARDIOVAS, V16, P371, DOI 10.1016/j.numecd.2006.01.012
  24. PO Kwiterovich Jr, 2000, AM J CARDIOL, V86, P452
  25. Stein O, 2005, ATHEROSCLEROSIS, V178, P217, DOI 10.1016/j.atherosclerosis.2004.10.008
  26. Tzotzas T, 2009, OBES REV, V10, P403, DOI 10.1111/j.1467-789X.2009.00586.x
  27. Wang CS, 2004, CHEM REV, V104, P119